Aided by a better understanding of breast cancer biology, treatments for primary and metastatic breast cancers have achieved significant advances in recent years, said the Breast Cancer Society of Taiwan, which is holding the “2013 Taipei International Breast Cancer Symposium” this weekend, with the attendance of Hematology-Oncology head Dennis Slamon, whose research has led to the development of a new targeted breast cancer treatment, which may improve treatment for about 25 percent of the breast cancer patients who have a specific genetic alteration.
Slamon discovered that women suffering from cancers with an over-expression of HER 2 protein in tumors are at a higher risk of cancer recurrence and distant metastasis.
The subsequent discovery of the antibodies against HER2, accompanied by a series of clinical trials, resulted in a targeted therapy for HER 2 positive breast cancer patients, which reduces the rate of breast cancer recurrence by 50 percent, according to the society.
“And the HER 2 positive breast cancer population has gone from having the worst outcome among the breast cancers to now having the best outcome,” Slamon said.
Knowing whether the breast cancer is sensitive to hormones — hormone receptor (HR) positive or negative — and the level of human epidermal growth factor receptor 2 (HER2) helps determine what is the best treatment for the patient. All HR-positive breast cancers are to receive hormone therapy and the HER-2 positive breast cancer are to receive targeted therapy, chairman of the society Huang Chiun-Sheng (黃俊升) said.
As the binding of hormone estrogen receptor (ER) and estrogen can induce the growth of cancer cells and thus cancer recurrence after surgery, two approaches have been adopted to “downmodulate the estrogen activity,” Huang said. Anti-estrogens, such as tamoxifen, act as ER antagonists that can “inhibit the ER’s ability to bind estrogen,” and aromatase inhibitors (AI) can prevent the synthesis of estrogen.
About 60 percent to 66 percent of the breast cancer patients have HR-positive breast cancer, secretary general of BCST Tseng Ling-ming (曾令民) said.
“In recent years there have been promising advances in the treatment. It has been shown by studies that for postmenopausal women with HR positive early-stage breast cancer, five years of initial therapy with AI can better reduce the risk of recurrence and increase the survival than tamoxifen,” Tseng said.
“Also, a 10-year hormone therapy has also been shown to result in better patient outcome than a five-year one for women with HR positive cancers, who are at higher risk of recurrence five years after surgery [compared with those with HR negative cancers].”
“The third advance is the introduction of mTOR inhibitors for people with locally advanced or fourth-stage HR positive breast cancer, who have become resistant to hormone therapy and would have to resort to chemotherapy, which would compromise the quality of life for the patient,” Tseng added. “Using mTOR in combination with AI has been shown to be able to overcome resistance and achieve improvement in progression-free survival.”
Kenting National Park service technician Yang Jien-fon (楊政峰) won a silver award in World Grand Prix Photography Awards Spring Season for his photograph of two male rat snakes intertwined in combat. Yang’s colleagues at Kenting National Park said he is a master of nature photography who has been held back by his job in civil service. The awards accept entries in all four seasons across six categories: architectural and urban photography, black-and-white and fine art photography, commercial and fashion photography, documentary and people photography, nature and experimental photography, and mobile photography. Awards are ranked according to scores and divided into platinum, gold and
More than half of the bamboo vipers captured in Tainan in the past few years were found in the city’s Sinhua District (新化), while other districts had smaller catches or none at all. Every year, Tainan captures about 6,000 snakes which have made their way into people’s homes. Of the six major venomous snakes in Taiwan, the cobra, the many-banded krait, the brown-spotted pit viper and the bamboo viper are the most frequently captured. The high concentration of bamboo vipers captured in Sinhua District is puzzling. Tainan Agriculture Bureau Forestry and Nature Conservation Division head Chu Chien-ming (朱健明) earlier this week said that the
The first bluefin tuna of the season, brought to shore in Pingtung County and weighing 190kg, was yesterday auctioned for NT$10,600 (US$333.5) per kilogram, setting a record high for the local market. The auction was held at the fish market in Donggang Fishing Harbor, where the Siaoliouciou Island-registered fishing vessel Fu Yu Ching No. 2 delivered the “Pingtung First Tuna” it had caught for bidding. Bidding was intense, and the tuna was ultimately jointly purchased by a local restaurant and a local company for NT$10,600 per kilogram — NT$300 ,more than last year — for a total of NT$2.014 million. The 67-year-old skipper
BREACH OF CONTRACT: The bus operators would seek compensation and have demanded that the manufacturer replace the chips with ones that meet regulations Two bus operators found to be using buses with China-made chips are to demand that the original manufacturers replace the systems and provide compensation for breach of contract, the Veterans Affairs Council said yesterday. Democratic Progressive Party Legislator Michelle Lin (林楚茵) yesterday said that Da Nan Bus Co and Shin-Shin Bus Co Ltd have fielded a total of 82 buses that are using Chinese chips. The bus models were made by Tron-E, while the systems provider was CYE Electronics, Lin said. Lin alleged that the buses were using chips manufactured by Huawei subsidiary HiSilicon Co, which presents a national security risk if the
RSS